4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-024166
Director acquired 20,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2022-06-23 | Grant or award | +20,500 | 132,418 | D | ||
| Derivatives | |||||||
| Gallagher Carol Giltner Director | 2022-06-23 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +31,500 | 31,500 | D | ||
Loading xslF345X03/form4.xml…